2023Äê8ÔÂ24ÈÕ±±¾©Ê±¼äÖÐÎç12µã£¨ÈÕ±¾Ê±¼ä13µã£©£¬£¬£¬ÈÕ±¾¸£µºµÚÒ»ºËµçÕ¾Æô¶¯ºËÎÛȾˮÅź£ÍýÏ룬£¬£¬µ±ÈÕÒÑÍê³É200ÖÁ210¶ÖµÄºËÎÛȾˮÅÅ·Å¡£¡£¡£
¿ÉÒÔ¾ø²»¿äÕŵÄ˵£¬£¬£¬ÕâÊÇÒ»¼þΣº¦È«ÌåÈËÀàÉúÃüÇå¾²µÄÖØ´óÊÂÎñ¡£¡£¡£
×ÝÈ»ÒѾ¾ÓÉ´¦Öóͷ££¬£¬£¬ÈÕ±¾ºËÎÛË®ÖÐÈÔÈ»º¬Óв¿·Ö·ÅÉäÐÔÎïÖÊ£¬£¬£¬¶ÔÉú̬ÇéÐΡ¢ÈËÀ࿵½¡¶¼Óв»¿ÉºöÊÓµÄΣº¦£¬£¬£¬½«»áµ¼Ö°©Ö¢Î£º¦ÔöÌí¡¢·ÅÉ䲡Σº¦ÔöÌí¡¢º£ÑóÉúÎï·øÉäÎÛȾ¡¢º£Ñóµ×²ãÓÀÊÀÎÛȾµÈÑÏÖØÎÊÌâ¡£¡£¡£
²¢ÇÒÕâЩºËÎÛË®´ó×ÚÅÅ·ÅÈ뺣ºó£¬£¬£¬²¢·ÇֻͣÁôÔÚ¸£µºÖÜΧº£Óò£¬£¬£¬»¹»áËæ×ÅÑóÁ÷Ö𽥱鲼ËùÓдóÑ󣬣¬£¬Õâ¾ÍÒâζ×Å£¬£¬£¬È«Çò¶¼ÎÞ·¨×èÖ¹ÈÕ±¾ºËÎÛȾˮµÄÓ°Ïì¡£¡£¡£
ÏÖÔÚÈÕ±¾µÄºËÎÛË®×ÜÁ¿ÒѾÁè¼Ý130Íò¶Ö£¬£¬£¬Ëæ×ÅÈÕ±¾Öð²½ÊµÑéÅÅ·ÅÍýÏ룬£¬£¬µØÇò½«Êܵ½ÎÞ·¨ÐÞ¸´µÄÖØ´´¡£¡£¡£
ËäÈ»ÈÕ±¾Æ¬ÃæÐû²¼ÅŷŵĺËÎÛË®ÒѾ¡°µÖ´ï¡±Åŷűê×¼£¬£¬£¬µ«ÊÂÊµÕæµÄÊÇÕâÑùÂ𣿣¿£¿£¿
ÈÕ±¾¸£µººËÎÛË®Öк¬ÓÐë°¡¢Ì¼-14¡¢µâ-129µÈ60¶àÖÖ·ÅÉäÐÔÎïÖÊ£¬£¬£¬ÆäÖв¿·Ö·ÅÉäÐÔÎïÖʵÄÓк¦ÐÔÔÚǧÄêÄÚÒÀÈ»±£´æ£¬£¬£¬ºÃ±ÈºËÎÛË®Öк¬ÓеÄ̼-14£¬£¬£¬°ëË¥ÆÚ¾ÓÈ»³¤´ï5730Ä꣬£¬£¬¶øµâ-129µÄ°ëË¥ÆÚ¸ü³¤¡£¡£¡£
Ò²¾ÍÊÇ˵£¬£¬£¬ºËÎÛË®Öк¬ÓеIJ¿·Ö·ÅÉäÐÔÎïÖÊ×ÝÈ»ÊÇÔÚÊýǧÄêºó£¬£¬£¬ÈÔÈ»±£´æ²»µÍµÄ·øÉäÇ¿¶È¡£¡£¡£
ÏÖÔÚËäÈ»²»¿ÉÃ÷È·ÈÕ±¾ÅŷŵĺËÎÛË®ÖÐ60¶àÖÖ·ÅÉäÐÔÎïÖʵÄŨ¶ÈÏêϸÊýÖµ£¬£¬£¬µ«¿ÉÒÔÃ÷È·µÄÊÇ£¬£¬£¬ÈËÀ༴½«ÃæÁÙ°©Ö¢Î£º¦ÔöÌíµÄÑÏÖØÎÊÌâ¡£¡£¡£
ÖÚËùÖÜÖª£¬£¬£¬°©Ö¢µÄ±¬·¢ÊµÖÊÉÏÊÇÓÉ»ùÒòÍ»±äµ¼Öµģ¬£¬£¬¶øºã¾Ã´¦ÓÚ±£´æºË·øÉäµÄÇéÐÎÏ£¬£¬£¬±¬·¢»ùÒòÍ»±äµÄ¿ÉÄÜÐÔ¸ü¸ß¡£¡£¡£
ÔÚ2017Äê10ÔÂ27ÈÕ£¬£¬£¬ÌìÏÂÎÀÉú×éÖ¯¹ú¼Ê°©Ö¢Ñо¿»ú¹¹½«µçÀë·øÉ䣨°üÀ¨ºË·øÉ䣩ÁÐÈëÒ»ÀàÖ°©ÎïµÄÇåµ¥ÖС£¡£¡£
¶øÔÚ2011ÄêÈÕ±¾¸£µºµÄºË×ߩʹʺ󣬣¬£¬ÍâµØ×¡ÃñÒ»Ö±Éý¸ßµÄ¼××´ÏÙ°©¡¢°×Ѫ²¡µÄ·¢²¡ÂÊ£¬£¬£¬Ò²ÑéÖ¤Á˺˷øÉäÖ°©µÄÍþÁ¦¡£¡£¡£
ÔÚ´ËÔ½ÈÕ±¾¸£µºÅŷŵĺËÎÛË®ÖУ¬£¬£¬º¬ÓÐë°¡¢îÜ-60¡¢µâ-129¡¢ï¤-137ºÍïÈ-90µÈ´ó×Ú·ÅÉäÐÔÎïÖʲÐÁô¡£¡£¡£
ÆäÖУ¬£¬£¬ë°¿ÉÒÔÈËÌ寤·ôÎüÊÕ£¬£¬£¬Òà»òÊÇͨ¹ýÎüÈëÒѱ»ÎÛȾµÄË®ÕôÆø¡¢ÉãÈëÒѱ»ÎÛȾµÄʳÎïºÍË®µÈ·½·¨½øÈëÈËÌ壬£¬£¬Ò×ΣÏÕϸ°ûÒýÆð¼²²¡£¬£¬£¬ÉõÖÁÊÇÆÆËðϸ°û»ùÒò£¬£¬£¬µ¼Ö±äÒì¡¢°©±ä¡£¡£¡£
¶øµâ-129Ò×µ¼Ö¼××´ÏÙ°©¡¢ïÈ-90Ò×µ¼Ö°×Ѫ²¡£¬£¬£¬ï¤-137Ò×ÖÍÁôÔÚÈËÌåÄÚµ¼ÖÂÂѳ²°©¡¢°òë×°©¡¢°×Ѫ²¡£¬£¬£¬ÉõÖÁéæÃü¡£¡£¡£
ÒÔÊÇ£¬£¬£¬ÈÕ±¾´ó×ÚÅŷźËÎÛË®µÄÐÐΪ£¬£¬£¬½«´ó´óÔöÌí»¼°©Î£º¦£¬£¬£¬¶øÕâÑùµÄΣº¦½«Ëæ×ÅÑóÁ÷µÖ´ïÕû¸öº£Ñ󣬣¬£¬ÍþвȫÇòסÃñµÄ¿µ½¡¡£¡£¡£
¸ßЧ·À°©£¬£¬£¬½«°©Ö¢Ä¨É±ÔÚÒ¡ÀºÖÐ
¡°Î£ÄÑ¡±Ä¿½ñ£¬£¬£¬ÎÒÃǸÃÔõÑù½«°©Ö¢Ä¨É±ÔÚÒ¡ÀºÖУ¿£¿£¿£¿
ÒªÏ뽫°©Ï¸°ûÔÚÒ¡Àº½×¶ÎĨɱ£¬£¬£¬Äǿ϶¨Òª´ÓÃâÒßϸ°ûÈëÊÖ¡£¡£¡£
Õý³£ÇéÐÎÏ£¬£¬£¬µ±ÈËÌå·ºÆð°©Ï¸°ûʱ£¬£¬£¬ÃâÒßϵͳ»áÅɳöNKϸ°û£¨×ÔȻɱÉËϸ°û£©¡¢¾ÞÊÉϸ°û¡¢Tϸ°ûµÈÃâÒßϸ°ûÓÐÓÃʶ±ð²¢É¨³ý°©Ï¸°û£¬£¬£¬×èÖ¹°©Ï¸°ûµÄ¼ÌÐøÉú³¤¡£¡£¡£
µ«½ÆÕ©µÄ°©Ï¸°û×ÜÔÚÏë·½Ïë·¨¶ã¿ªÃâÒßϸ°ûµÄΧ׷Çжϣ¬£¬£¬ÈôÊÇÈËÌåµÄÃâÒßϸ°û²»·óǿʢ£¬£¬£¬¾ÍÎÞ·¨ÓÐÓÃʶ±ð´Ó¶ø»÷ɱ°©Ï¸°û¡£¡£¡£
ÒÔÊÇ£¬£¬£¬ÒªÏë´Ó»ù´¡ÉÏÓÐÓ÷À°©£¬£¬£¬¾ÍÐèҪ׳¸ÅÂÔÄÚµÄÃâÒßϸ°û²½¶Ó£¬£¬£¬´òÔìÒ»Ö§ÊýÄ¿¸»×ã¡¢ÍþÁ¦×ã¹»µÄ·À°©¾ü¶Ó£¬£¬£¬ÔÚÌåÄÚ·ºÆð°©Ï¸°ûʱ£¬£¬£¬½«ÆäĨɱÔÚÒ¡ÀºÖС£¡£¡£
ÔÚÖÚ¶àÃâÒßϸ°ûÖУ¬£¬£¬Tϸ°û¿ÉνÊÇÊÇÖ×ÁöµÄÌìµÐ£¬£¬£¬ÄÜÏñ×¼È·ÖÆµ¼µÄµ¼µ¯£¬£¬£¬×¼È·Ê¶±ð°©Ï¸°û£¬£¬£¬²¢Í¨¹ýÊÍ·Å´©¿×ËØ¿ÅÁ£Ã¸£¬£¬£¬ÔÚ°©Ï¸°ûÍâò´ò¿×£¬£¬£¬½ø¶øÒýÆðÖ×Áöϸ°ûÁѽ⣬£¬£¬ÓÕµ¼Ö×Áöϸ°ûµòÍö¡£¡£¡£
Òò´Ë£¬£¬£¬ÎªÁ˵ִï¸ßЧ·À°©µÄÄ¿µÄ£¬£¬£¬Ó¦ÓÃϸ°ûÊÖÒÕÄÜʰ빦±¶¡£¡£¡£
¶ø±ÈÕÕÆäËüȪԴµÄTϸ°û£¬£¬£¬Æê´øÑªÈªÔ´µÄTϸ°û´¦ÓÚδ·Ö½â״̬£¬£¬£¬¾ßÓи߶ȵĶàÑùÐÔ£¬£¬£¬Ò²Óм«Ç¿µÄÀ©ÔöÄÜÁ¦ºÍ¸üÓÐÓõİÐÏòÐÔ£¬£¬£¬¿ÉÖ±½Óɨ³ýÒ쳣ϸ°û¡¢Ö×Áöϸ°û¡£¡£¡£
2015Ä꣬£¬£¬ÆÚ¿¯¡¶Blood¡·ÉϽÒÏþµÄÌâΪ¡°Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells¡±µÄÑо¿Ð§¹û£¬£¬£¬Ö¤ÊµÁËÓëÍâÖÜѪTϸ°ûÏà±È£¬£¬£¬Æê´øÑªÈªÔ´µÄTϸ°ûÓµÓиüÇ¿µÄ¿¹Ö×Áö×÷Óᣡ£¡£
³ýÁ˾߱¸¸üÇ¿µÄ¿¹Ö×ÁöЧ¹û£¬£¬£¬Æê´øÑªTϸ°û»¹¾ßÓÐÒÔÏÂÓÅÔ½µÄÌØµã£º
1¡¢ÈªÔ´ÓÚ¿µ½¡²ú¸¾Æê´øÑª£¬£¬£¬ÈªÔ´ÆÕ±é£¬£¬£¬Ò×ÊÕÂÞ£»£»£»£»
2¡¢ÃâÒßÔÐԵ͡¢×éÖ¯ÏàÈÝÐԺ㬣¬£¬²»Ò×±¬·¢ÒÆÖ²ÎËÞÖ÷²¡£¡£¡£»£»£»£»
3¡¢ÖÉ×ÓTϸ°ûÊýÄ¿½Ï¶à£¬£¬£¬¿ÉÌáÉýϸ°ûµÄ¶àÑùÐÔÓëÊýÄ¿£»£»£»£»
Ò²¾ÍÊÇ˵£¬£¬£¬ÔöÇ¿Æê´øÑªTϸ°û£¬£¬£¬¿ÉÓÐÓõִï·À°©µÄÄ¿µÄ£¬£¬£¬½µµÍ»¼°©µÄ¿ÉÄÜ¡£¡£¡£
×ܽá
ÈÕ±¾´ó×ÚÅŷźËÎÛË®µÄÐÐΪ£¬£¬£¬¸øÈ«ÇòÉú̬ÇéÐΡ¢È«ÌåÈËÀ࿵½¡¶¼´øÀ´Á˺˷øÉäµÄÍþв£¬£¬£¬µ¼Ö»¼°©Î£º¦ÏÔÖøÔöÌí¡£¡£¡£
ÃâÒßϸ°ûÊÇ·À°©µÄµÚÒ»Õ½Ïߣ¬£¬£¬¶øÆê´øÑªÈªÔ´µÄTϸ°û¾ßÓиüÇ¿µÄÔöÖ³ÄÜÁ¦ºÍ¸üÓÐÓõİÐÏòÐÔ£¬£¬£¬¿ÉÖ±½Óɨ³ýÖ×Áöϸ°û¡£¡£¡£
Òò´Ë£¬£¬£¬ÔöÇ¿Æê´øÑªÈªÔ´µÄTϸ°ûÓÐÍû½«°©Ö¢Ä¨É±ÔÚÒ¡ÀºÖУ¡
²Î¿¼ÎÄÏ×£º
1¡¢Hiwarkar P, Qasim W, Ricciardelli I, Gilmour K, Quezada S, Saudemont A, Amrolia P, Veys P. Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells. Blood. 2015 Dec 24;126(26):2882-91. doi: 10.1182/blood-2015-06-654780. Epub 2015 Oct 8. PMID: 26450984.